Micron Technology has broken ground on a massive new NAND fabrication facility in Singapore, a decade-long, $24 billion project aimed at meeting explosive demand for AI and data storage. The move signals a strategic long-term pivot but raises questions about market cycles and capital discipline.
While voice-AI firms like SoundHound capture headlines, data analytics giant Palantir Technologies leverages deep government ties and enterprise contracts to build a potentially more resilient growth narrative in the volatile AI sector.
Across India's villages and small towns, a new generation of workers is logging on after sunset to label the data that trains the world's most advanced AI systems. This quiet workforce, many of them women and first-generation graduates, is finding economic opportunity while reshaping global tech's supply chain.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
While flashy jets and missiles capture public attention, L3Harris Technologies operates in the critical, unseen layers of connectivity and electronic warfare. As global tensions and technological threats evolve, its role as a foundational enabler of next-generation defense systems is driving a compelling investment thesis centered on resilience and information dominance.
Cloud provider CoreWeave faces investor lawsuits over capacity claims just as Nvidia doubles down with a major investment, placing the company at the center of a high-stakes debate on AI infrastructure's future.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
As wireless networks strain under exponential data growth, AT&T's vast fiber infrastructure and deep spectrum portfolio are emerging as critical competitive advantages, setting the stage for a potential market rerating.
As the AI infrastructure race intensifies, a critical bottleneck is emerging: memory. With demand for high-bandwidth memory (HBM) skyrocketing, Micron Technology finds itself at the center of a new investment thesis, drawing comparisons to the early days of Nvidia's AI-driven ascent.
The Department of Justice may challenge a federal judge's order to release a five-year-old boy and his father from immigration detention, a case that has ignited debate over the administration's aggressive enforcement tactics and the conditions inside family detention centers.
NXP Semiconductors sharpens its strategic focus on the connected car, divesting its MEMS sensor business while snapping up Aviva Links to enhance its high-speed data link portfolio for next-generation vehicles.
Elon Musk merges his space and AI ambitions under one roof as SpaceX finalizes the acquisition of xAI. The strategic move, combining Starlink, social platform X, and chatbot Grok, sets the stage for a landmark public offering and accelerates Musk's vision for off-planet data infrastructure.
The Bureau of Labor Statistics has postponed the release of January's highly anticipated employment data due to a partial federal funding lapse, marking the latest economic disruption from Washington's budget impasse.
As stock markets cool from years of stellar gains, a disciplined rebalancing is underway. Vanguard data reveals a broad-based move into fixed income, signaling a strategic pivot rather than panic.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
U.S. stock futures pointed lower Monday, extending Friday's sell-off fueled by inflation concerns, a hawkish Fed chair nominee, and a brutal commodities rout. Wall Street analysts scrambled to adjust ratings on major tech and energy names amid the shifting landscape.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Tesla's decision to end production of flagship models and a sharpened focus on AI and robotics, coupled with losing its top EV sales crown to BYD, signals a profound strategic shift that is reshaping investor perceptions of the company's core identity.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
Western Digital leverages strong quarterly results and new customer deals to outline its long-term AI storage strategy at its Innovation Day event, as investors weigh its positioning in the booming data infrastructure market.
